← Back to Search

Intervention: NET+G for Post-Traumatic Stress Disorder

N/A
Waitlist Available
Led By Simon Hatcher, MD
Research Sponsored by University of Ottawa
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights

Summary

The purpose of this study is to assess the acceptability and feasibility of delivering Narrative Exposure Therapy to homeless individuals with Post-Traumatic Stress Disorder. In Ottawa, in 2015, there were 6,825 people using 500,191 bed nights in the city emergency shelters (Alliance to End Homelessness in Ottawa 2015 Annual Report) with approximately another 500 sleeping on the streets (The Homelessness Community Capacity Building Steering Committee 2008 Ottawa, ON). Mental health disorders, including substance abuse, are common in this population, are often under treated and can be a source of considerable distress and disability. In addition to the high rates of mental disorder, there are three other significant factors which impact morbidity. First, a history of significant childhood trauma is common which impacts relationships and ability to cope with difficulties. It is increasingly recognized that a trauma informed approach to providing services to the homeless population is needed. There have been no randomized controlled trials of treatment of post-traumatic stress disorder in the homeless population. Second, brain dysfunction from head injuries and attention deficit disorder appear to be common. Problems with brain dysfunction can cause difficulties especially with attention, impulsivity and managing relationships. Finally, life for the marginally housed can be chaotic with day-to-day uncertainty over accommodation, income and security. This means that providing health services to this population requires a degree of flexibility in terms of who provides services, where and when. These issues result in a population with complex needs that traditional mental health care is poorly equipped to serve. At present there is a clear gap in the provision of services that address the experience of trauma in homeless individuals. There are no services for trauma in publicly funded hospitals, which leaves private providers as the sole source of treatment. Other potential barriers include accounting for the effects of substance abuse, brain injury and "chaos" in this population. What the investigators are proposing is a pilot study to assess the feasibility and acceptability of providing a time-limited assessment and therapy (six sessions) within the shelter system to homeless individuals diagnosed with post-traumatic stress disorder.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Acceptability measured by Recruitment Rates
Feasibility measured by Sample Size
Secondary study objectives
Acceptability & Feasibility of Collecting Outcome Data measured by Retention Rates
Change in Health Care Costs as measured by Self-Report Questionnaire
Change in Housing Status as measured by Self-Report from Participants
+4 more
Other study objectives
Demographic Characteristics as measured by Self-Report
Diagnosis of PTSD as measured by the MINI International Neurpsychiatric Interview
Level of Cognitive Functioning as measured by the Montreal Cognitive Assessment (MoCA)
+1 more

Trial Design

2Treatment groups
Active Control
Group I: Intervention: NET+GActive Control2 Interventions
In addition to usual care, participants will receive six sessions of Narrative Exposure Therapy over six weeks plus the option to receive genealogical services.
Group II: Intervention: NETActive Control1 Intervention
In addition to usual care, participants will receive six sessions of Narrative Exposure Therapy over six weeks.

Find a Location

Who is running the clinical trial?

Ottawa Hospital Research InstituteOTHER
572 Previous Clinical Trials
2,789,007 Total Patients Enrolled
University of OttawaLead Sponsor
213 Previous Clinical Trials
268,257 Total Patients Enrolled
Simon Hatcher, MDPrincipal InvestigatorUniversity of Ottawa
1 Previous Clinical Trials
~2 spots leftby Sep 2025